19 May 2013
Keywords: medarex/b-ms, delay, company, medarex, drug, major, bristol-myers
Article | 05 May 2008
US company Medarex and drug major Bristol-Myers Squibb will delay the application process for their cancer drug candidate ipilimumab to ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
5 May 2008
17 May 2013
© 2013 thepharmaletter.com